Similar articles

• In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

  Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. Naldini L, et al. Science. 1996 Apr 12;272(5259):263-7. doi: 10.1126/science.272.5259.263. Science. 1996. PMID: 8602510
• HIV-1 Vpr potently induces programmed cell death in the CNS in vivo.

  Cheng X, Mukhtar M, Acheampong EA, Srinivasan A, Rafi M, Pomerantz RJ, Parveen Z. Cheng X, et al. DNA Cell Biol. 2007 Feb;26(2):116-31. doi: 10.1089/dna.2006.0541. DNA Cell Biol. 2007. PMID: 17328670
• The vpr regulatory gene of HIV.

  Levy DN, Refaeli Y, Weiner DB. Levy DN, et al. Curr Top Microbiol Immunol. 1995;193:209-36. doi: 10.1007/978-3-642-78929-8_11. Curr Top Microbiol Immunol. 1995. PMID: 7648876 Review. No abstract available.
• Lentiviral vectors--the promise of gene therapy within reach?

  Amado RG, Chen IS. Amado RG, et al. Science. 1999 Jul 30;285(5428):674-6. doi: 10.1126/science.285.5428.674. Science. 1999. PMID: 10454923 No abstract available.
• [Functional roles of HIV-1 accessory genes for its pathogenicity].

  Adachi A, Kamada K, Hatcho K, Yamashita T, Uchiyama T, Nomaguchi M. Adachi A, et al. Tanpakushitsu Kakusan Koso. 2007 Aug;52(10 Suppl):1261-7. Tanpakushitsu Kakusan Koso. 2007. PMID: 17824250 Review. Japanese. No abstract available.